Share-based Payment Arrangement, Expense of BioAge Labs, Inc. from 30 Sep 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BioAge Labs, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2023 to 30 Sep 2025.
  • BioAge Labs, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2,791,000, a 51% increase year-over-year.
  • BioAge Labs, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $11,690,000.
  • BioAge Labs, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $6,979,000, a 131% increase from 2023.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

BioAge Labs, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $11,690,000 $2,791,000 +$943,000 +51% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $10,747,000 $3,229,000 +$1,671,000 +107% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $9,076,000 $2,949,000 +$2,097,000 +246% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $6,979,000 $2,721,000 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
Q3 2024 $1,848,000 +$1,091,000 +144% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $1,558,000 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $852,000 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q3 2023 $757,000 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3

BioAge Labs, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $6,979,000 +$3,963,000 +131% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
2023 $3,016,000 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.